The outlook for initial public offerings in 2025 remains buoyant in the GCC after a bumper 2024 that saw 53 IPOs on the back ...

PRIVATE equity (PE) and venture capital (VC) funds in China had another gloomy year in 2024, but many in the industry are ...

There's no denying Tesla has been the centerpiece of the electric vehicle (EV) revolution to date. And rightfully so. It didn ...

Shares of Quadrant Future IPO is trading at a premium of ₹145 in the grey market, as per market observers on January 12. The ...

Business conditions look good with the new federal administration to go public, but first do your preparation. Timing is ...

Stay away from Diginex Limited's IPO due to declining revenue, high debt, and intense competition in the ESG market. Read ...

Energy equipment and services provider Flowco launched the year’s first major IPO, planning to raise $392 million and list in ...

Southeast Asia’s equity capital markets reached a grim milestone in 2024, as IPO activity plunged to its lowest in nearly a ...

Metsera files for IPO, developing GLP-1 drug MET-097i and other obesity treatments to compete with Eli Lilly and Novo Nordisk ...

Metsera has filed for an initial public offering. The clinical-stage biopharmaceutical company submitted a registration statement to regulators on Friday, saying it intends to list under the ticker ...

Metsera, founded in 2022 by venture capital firm ARCH Venture and investment firm Population Health Partners, revealed a net ...

The SPAC is offering up to $8.3 million worth of private placement units, committed by sponsors and independent director nominees. It also has provided 7.2 million Class B shares to initial ...